Exagen reports preliminary 2025 revenue of $66M to $67M
Go back to Exagen reports preliminary 2025 revenue of $66M to $67M| (NASDAQ: XGN) | Delayed: 7.14 +0.17 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.97 | 52 Week High | $0.46 | |||
| Open | $7.10 | 52 Week Low | $0.46 | |||
| Day High | $7.29 | P/E | N/A | |||
| Day Low | $7.09 | EPS | $0.00 | |||
| Volume | 356,425 | |||||

